Department of Chemistry, Faculty of Mathematics and Natural Sciences, Padjadjaran University, Sumedang 45363, Indonesia.
Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Padjadjaran University, Sumedang 45363, Indonesia.
Molecules. 2022 Nov 18;27(22):8009. doi: 10.3390/molecules27228009.
Natural compounds provide precursors with various pharmacological activities and play an important role in discovering new chemical entities, including radiopharmaceuticals. In the development of new radiopharmaceuticals, iodine radioisotopes are widely used and interact with complex compounds including natural products. However, the development of radiopharmaceuticals from natural compounds with iodine radioisotopes has not been widely explored. This review summarizes the development of radiopharmaceuticals from natural compounds using iodine radioisotopes in the last 10 years, as well as discusses the challenges and strategies to improve future discovery of radiopharmaceuticals from natural resources. Literature research was conducted via PubMed, from which 32 research articles related to the development of natural compounds labeled with iodine radioisotopes were reported. From the literature, the challenges in developing radiopharmaceuticals from natural compounds were the purity and biodistribution. Despite the challenges, the development of radiopharmaceuticals from natural compounds is a golden opportunity for nuclear medicine advancement.
天然化合物提供具有各种药理活性的前体,在发现新的化学实体方面发挥着重要作用,包括放射性药物。在新放射性药物的开发中,碘放射性同位素被广泛应用,并与包括天然产物在内的复杂化合物相互作用。然而,利用碘放射性同位素从天然化合物中开发放射性药物尚未得到广泛探索。本综述总结了过去 10 年利用碘放射性同位素从天然化合物中开发放射性药物的情况,并讨论了提高未来从自然资源中发现放射性药物的挑战和策略。通过 PubMed 进行文献研究,共报道了 32 篇与碘放射性同位素标记天然化合物开发相关的研究文章。从文献中可以看出,从天然化合物中开发放射性药物的挑战在于纯度和生物分布。尽管存在挑战,但从天然化合物中开发放射性药物是核医学发展的黄金机会。